Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Balance Sheet 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Total Assets | 4.63B | 3.72B | 3.25B | 2.37B | 2.07B | 1.73B | 1.31B | 993.2M | 817.6M | 365.1M | 474.8M | 243.0M | 154.7M | 196.0M | 138.4M | 144.4M |
| Cash & Equivalents | 713.0M | 233.0M | 251.1M | 262.9M | 340.8M | 187.1M | 112.3M | 141.7M | 254.7M | 83.3M | 74.2M | 31.0M | 44.8M | 63.8M | 50.1M | 54.1M |
| Liabilities | ||||||||||||||||
| Total Liabilities | 1.38B | 1.13B | 1.02B | 660.9M | 698.5M | 608.5M | 669.1M | 512.4M | 445.5M | 50.2M | 50.3M | 34.3M | 34.3M | 41.6M | 78.3M | 125.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity | ||||||||||||||||
| Shareholders' Equity | 3.25B | 2.59B | 2.23B | 1.71B | 1.37B | 1.13B | 636.9M | 480.8M | 372.2M | 314.9M | 424.5M | 208.7M | 120.4M | 154.4M | 60.1M | 19.3M |
Neurocrine Biosciences Inc. Balance Sheet — FAQ
Neurocrine Biosciences Inc. (NBIX) balance sheet over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's balance sheet history?
The chart and table above show Neurocrine Biosciences Inc.'s balance sheet by year and by quarter, including the growth rate.